Further analysis revealed that there was also no significant difference in the percentages of patients with DFS between these subgroups (p>0.05 for all, Figure 2B–F), suggesting that the age, larger tumor size, positive microinvasive, higher tumor grade, and Ki67 levels were not associated with increased risk of worse DFS in this population. This evidence concerns the gene MKI67 and neoplasm.